From: A systematic survey of randomised trials that stopped early for reasons of futility
Characteristics | Â | N |
---|---|---|
Trial design | Parallel/ Factorial/ Cross-over/Cluster | 50/0/0/2 |
Trial centres | Single | 4 |
 | Multiple, national | 22 |
 | Multiple, international | 24 |
 | Unclear | 2 |
Setting | Outpatient/ Inpatient / Acute care | 33/ 11/ 8 |
Clinical area | Oncology | 16 |
 | Cardiovascular research | 9 |
 | Mental health | 4 |
 | Obstetrics and gynaecology | 4 |
 | Infectious diseases | 3 |
 | Surgery | 3 |
 | Gastrointestinal | 3 |
 | Intensive care | 3 |
 | Othera | 7 |
Type of intervention | Drug/ Surgical procedure/ Other | 41/ 3 / 8 |
Type of control | Active intervention/ placebo/ no intervention | 14/31/ 7 |
Trial sponsor | Industry/ Non-industry | 21/31 |
Data safety and monitoring board | Yes/No | 36/ 16 |
CONSORT mentioned | Yes/No | 10/ 42 |
Published protocol | Journal publication/ Trial registry only /Not reported | 4/ 22/ 26 |